CellBion
Advancing Global Healthcare with Innovative Radiopharmaceuticals
Korea South
6 employees
Venture round
Total: $8.00B
Biotechnology, Health and Wellness +1
General Information
Korea South
BounceWatch is an independent company data service, not affiliated with CellBion. To contact CellBion, visit cellbion.co.kr.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CellBion compare?
A PDF of CellBion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CellBion soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Korea South Market
Biotechnology
About CellBion
Business keywords: radiopharmaceuticals, precision medicine, medical imaging, therapeutic solutions, patient outcomes, technology, global impact
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | KRW8.00B | 3 |
|
26 Oct 2023 |
| Venture Round | Undisclosed | 1 |
|
01 Jan 2019 |
| Venture Round | Undisclosed | 1 |
|
01 Jan 2012 |
CellBion Alternatives & Competitors
View All Alternatives
Our Mission: Providing Patients Global Access to Game-Changing Radiopharmaceuticals
Clarity is developing next-generation products to address the growing need for radiopharmaceuticals...
Join us at ProNova in shaping the future of cancer treatment.
FAQ About CellBion
Source: BounceWatch company record for CellBion, https://bouncewatch.com/company/cellbion, updated 30 December 2024. When citing, please name BounceWatch and link this page.
